Evidence map›Paper›PMID 39909450›Full record

ArticleFukushima journal of medical science2025

Three cases of gastrointestinal stromal tumors with metaiodobenzylguanidine (MIBG) accumulation.

Honami Kobiyama, Shiro Ishii, Yumi Saito, Natsumi Kawamoto, Shigeyasu Sugawara, Hiroshi Ito

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Fukushima journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Honami KobiyamaDepartment of Radiology and Nuclear Medicine, Fukushima Medical University.
Shiro IshiiDepartment of Radiology and Nuclear Medicine, Fukushima Medical University.
Yumi SaitoDepartment of Radiology and Nuclear Medicine, Fukushima Medical University.
Natsumi KawamotoDepartment of Radiology and Nuclear Medicine, Fukushima Medical University.
Shigeyasu SugawaraDepartment of Radiology and Nuclear Medicine, Fukushima Medical University.
Hiroshi ItoDepartment of Radiology and Nuclear Medicine, Fukushima Medical University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meta-iodobenzylguanidine (MIBG) is an analog of norepinephrine and guanethidine, and MIBG scintigraphy is useful to diagnose tumors of the sympathetic nervous system, such as pheochromocytoma, paraganglioma, and neuroblastoma.　To date, there have been few reports of MIBG accumulation in gastrointestinal stromal tumors (GISTs), so the mechanism and frequency of MIBG accumulation in GISTs are unknown.　Herein, we report and discuss three cases of GIST in which scintigraphy that was performed to exclude pheochromocytoma showed MIBG accumulation.

Indexed as

3-IodobenzylguanidineGastrointestinal Stromal TumorsRadiopharmaceuticalsAdultAgedFemaleHumansMaleMiddle AgedRadionuclide Imaging3-IodobenzylguanidineRadiopharmaceuticalsgastrointestinal stromal tumor (GIST)metaiodobenzylguanidine (MIBG)

Identifiers

PMID39909450
PMCPMC12079052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.